Dr. Stacey Adam is the Director of Cancer Research Partnerships at the Foundation for the National Institute of Health (FNIH). The Major partnerships she oversees at FNIH are the Partnership for Accelerating Cancer Therapies (PACT), the Lung Master protocol (Lung-MAP) clinical trial, and the cancer steering committee of the Biomarkers Consortium. She is a molecular pharmacologist/cancer biologist versed in multiple facets of cancer research, project and team management, and healthcare and research strategy consulting.
Prior to FNIH, Dr. Adam was a Manager at Deloitte Consulting within the Federal Life Sciences and Healthcare Strategy practice where she supported many federal and non-profit client projects. Before Deloitte, Dr. Adam conducted her postdoctoral fellowship at Stanford University School of Medicine, Department of Oncology where she was both an NIH and American Cancer Society supported fellow. While at Stanford, she focused on developing better models for drug target discovery in pediatric cancer both through animal modeling and systems biology. Dr. Adam earned her Ph.D. degree in Pharmacology from Duke University. She also holds a BS in Clinical Laboratory Science from the University of Nebraska-Medical Center.